A Physiologic Approach to Diagnosis of the Cushing Syndrome

Annals of Internal Medicine

Volumn 138, Issue 12, 2003, Pages 980-991

  Raff, Hershel ^a,b   Findling, James W ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b ST LUKE S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTICOTROPIN; DEXAMETHASONE; HYDROCORTISONE;

CIRCADIAN RHYTHM; CORTICOTROPIN BLOOD LEVEL; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; HORMONAL REGULATION; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; RELIABILITY; REVIEW; SALIVA LEVEL; SENSITIVITY AND SPECIFICITY; STRESS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; PHYSIOLOGY;

CUSHING SYNDROME; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM;

EID: 0037794186     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-138-12-200306170-00010     Document Type: Review

References (73)

1. Cushing H. The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bulletin of Johns Hopkins Hospital. 1932;50:137-95.
2. Archard C, Thiers J. Le virlisme pilaire et son association a l'insuffisance glycolytique (diabète des femmes a barb). Bull Acad Natl Med. 1921;86:51-64.
3. Terzolo M, Pia A, Ali A, Osella G, Reimondo G, Bovio S, et al. Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab. 2002;87:998-1003. [PMID: 11889151]
4. Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B, Winkelmann W. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome. J Clin Endocrinol Metab. 1992;75:826-32. [PMID: 1517373]
5. Leibowitz G, Tsur A, Chayen SD, Salameh M, Raz I, Cerasi E, et al. Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients. Clin Endocrinol (Oxf). 1996;44:717-22. [PMID: 8759185]
6. Contreras LN, Cardoso E, Lozano MP, Pozzo J, Pagano P, Claus-Hermbeg H. Detección de síndrome de Cushing preclínico en pacientes con sobrepeso y diabetes mellitas tipo 2. Medicina. 2000;60:326-30.
7. Richards JS. New signaling pathways for hormones and cyclic adenosine 3′,5′-monophosphate action in endocrine cells. Mol Endocrinol. 2001;15:209-18. [PMID: 11158328]
8. Findling JW, Raff H. Ectopic ACTH. In: Mazzaferri EL, Samaan NA, eds. Endocrine Tumors. Cambridge, MA: Blackwell Scientific; 1993:554-66.
9. Dallman MF, Akana SF, Scribner KA, Bradbury MJ, Walker CD, Strack AM, et al. Stress, feedback and facilitation in the hypothalamo-pituitary-adrenal axis. J Neuroendocrinol. 1991;4:517-26.
10. Jacobson L, Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev. 1991;12:118-34. [PMID: 2070776]
11. Dallman MF, Akana SF, Levin N, Walker CD, Bradbury MJ, Suemaru S, et al. Corticosteroids and the control of function in the hypothalamo-pituitary-adrenal (HPA) axis. Ann N Y Acad Sci. 1994;746:22-31. [PMID: 7825879]
12. Aguilera G, Rabadan-Diehl C. Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation. Regul Pept. 2000;96:23-9. [PMID: 11102648]
13. Raff H. Interactions between neurohypophyseal hormones and the ACTH-adrenocorrical axis. In: North WG, Moses AM, Share L, eds. The Neurohypophysis: A Window on Brain Function. New York: New York Academy of Sciences; 1993:411-25.
14. Born J, Fehm HL Hypothalamus-pituitary-adrenal activity during human sleep: a coordinating role for the limbic hippocampal system. Exp Clin Endocrinol Diabetes. 1998;106:153-63. [PMID: 9710353]
15. Bierwolf C, Kern W, Molle M, Born J, Fehm. HL Rhythms of pituitary-adrenal activity during sleep in patients with Cushing's disease. Exp Clin Endocrinol Diabetes. 2000;108:470-9. [PMID: 11083068]
16. Mendel CM. The free hormone hypothesis: a physiologically based mathematical model. Endocr Rev. 1989;10:232-74. [PMID: 2673754]
17. Wehling M. Specific, nongenomic actions of steroid hormones. Annu Rev Physiol. 1997;59:365-93. [PMID: 9074769]
18. McEwen BS. The brain is an important target of adrenal steroid actions. A comparison of synthetic and natural steroids. Ann N Y Acad Sci. 1997;823:201-13. [PMID: 9292046]
19. Seckl JR, Walker BR. Minireview: 11β-hydroxysteroid dehydrogenase type 1 - a tissue-specific amplifier of glucocorticoid action. Endocrinology. 2001;142:1371-6. [PMID: 11250914]
20. Stewart PM, Whorwood CB, Walker BR. Steroid hormones and hypertension: the cortisol-cortisone shuttle. Steroids. 1993;58:614-20. [PMID: 8116018]
21. Tomlinson JW, Draper N, Mackie J, Johnson AP, Holder G, Wood P, et al. Absence of Cushingoid phenotype in a patient with Cushing's disease due to defective cortisone to cortisol conversion. J Clin Endocrinol Metab. 2002;87:57-62. [PMID: 11788623]
22. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science. 2001;294:2166-70. [PMID: 11739957]
23. Cizza G, Nieman LK, Doppman JL, Passaro MD, Czerwiec FS, Chrousos GP, et al. Factitious Cushing syndrome. J Clin Endocrinol Metab. 1996;81:3573-7. [PMID: 8855803]
24. Raff H. Suppression of the hypothalamic-pituitary-adrenal axis and other systemic effects of inhaled corticosteroids in asthma. The Endocrinologist. 1998;8:9-14.
25. Findling JW, Raff H. Newer diagnostic techniques and problems in Cushing's disease. Endocrinol Metab Clin North Am. 1999;28:191-210. [PMID: 10207691]
26. Findling JW, Raff H. Diagnosis and differential diagnosis of Cushing's syndrome. Endocrinol Metab Clin North Am. 2001;30:729-47. [PMID: 11571938]
27. Kaltsas GA, Korbonits M, Isidori AM, Webb JA, Trainer PJ, Monson JP, et al. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome? Clin Endocrinol (Oxf). 2000;53:493-500. [PMID: 11012575]
28. Starkman MN, Schteingart DE. Neuropsychiatric manifestations of patients with Cushing's syndrome. Relationship to cortisol and adrenocorticotropic hermone levels. Arch Intern Med. 1981;141:215-9. [PMID: 6257194]
29. Newell-Price J, Trainer P, Perry L, Wass J, Grossman A, Besser M. A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome. Clin Endocrinol (Oxf). 1995;43:545-50. [PMID: 8548938]
30. Papanicolaou DA, Yanovski JA, Cutler GB Jr, Chrousos GP, Nieman LK. A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states. J Clin Endocrinol Metab. 1998;83:1163-7. [PMID: 9543134]
31. Gorges R, Knappe G, Gerl H, Ventz M, Stahl F. Diagnosis of Cushing's syndrome: re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group. J Endocrinol Invest. 1999;22:241-9. [PMID: 10342356]
32. Castro M, Elias PC, Martinelli CE Jr, Antonini SR, Santiago L, Moreira AC. Salivary cortisol as a tool for physiological studies and diagnostic strategies. Braz J Med Biol Res. 2000;33:1171-5. [PMID: 11004717]
33. Raff H. Salivary cortisol: a useful measurement in the diagnosis of Cushing's syndrome and the evaluation of the hypothalamic-pituitary-adrenal axis. The Endocrinologist. 2000;10:9-17.
34. Laudat MH, Cerdas S, Fournier C, Guiban D, Guilhaume B, Luton JP. Salivary cortisol measurement: a practical approach to assess pituitary-adrenal function. J Clin Endocrinol Metab. 1988;66:343-8. [PMID: 2828410]
35. Raff H, Raff JL, Findling JW. Late-night salivary cortisol as a screening test for Cushing's syndrome. J Clin Endocrinol Metab. 1998;83:2681-6. [PMID: 9709931]
36. Castro M, Elias PC, Quidute AR, Halah FP, Moreira AC. Out-patient screening for Cushing's syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests. J Clin Endocrinol Metab. 1999;84:878-82. [PMID: 10084565]
37. Gafni RI, Papanicolaou DA, Nieman LK Nighttime salivary cortisol measurement as a simple, noninvasive, outpatient screening test for Cushing's syndrome in children and adolescents. J Pediatr. 2000;137:30-5. [PMID: 10891818]
38. Martinelli CE Jr, Sader SL, Oliveira EB, Daneluzzi JC, Moreira AC. Salivary cortisol for screening of Cushing's syndrome in children. Clin Endocrinol (Oxf). 1999;51:67-71. [PMID: 10468967]
39. Papanicolaou DA, Mullen N, Kyrou I, Nieman LK. Nighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome, J Clin Endocrinol Metab. 2002;87:4515-21. [PMID: 12364428]
40. Raff H, Homar PJ, Skoner DP. New enzyme immunoassay for salivary cortisol [Letter]. Clin Chem. 2003;49:203-4. [PMID: 12507989]
41. Raff H, Homar PJ, Burns EA. Comparison of two methods for measuring salivary cortisol [Letter]. Clin Chem. 2002;48:207-8. [PMID: 11751565]
42. Murphy BE. Urinary free cortisol determinations: what they measure. The Endocrinologist. 2002;12:143-50.
43. Lin CL, Wu TJ, Machacek DA, Jiang NS, Kao PC. Urinary free cortisol and cortisone determined by high performance liquid chromatography in the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab. 1997;82:151-5. [PMID: 8989250]
44. Nieman LK, Cutler GB Jr. The sensitivity of the urine free cortisol measurement as a screening test for Cushing's syndrome [Abstract]. In: Programs and Abstracts of the Endocrine Society 72nd Annual Meeting. Atlanta, GA: Endocrine Soc; 1990:822.
45. Findling JW, Pinkstaff SM, Shaker JL, Raff H, Nelson JC. Pseudohypercortisoluria: spurious elevation of urinary cortisol due to carbamazepine. The Endocrinologist. 1998;8:51-4.
46. Meikle AW, Findling JW, Kushnir MM, Rockwood AL, Nelson GJ, Terry AH. PseudoCushings syndrome caused by fenofibrate interference with urinary cortisol assayed by HPLC. J Clin Endocrinol Metab [In press].
47. Mericq MV, Cutler GB Jr. High fluid intake increases urine free cortisol excretion in normal subjects. J Clin Endoctinol Metab. 1998;83:682-4. [PMID: 9467592]
48. Ramirez G, Gomez-Sanchez C, Meikle WA, Jubiz W. Evaluation of the hypothalamic hypophyseal adrenal axis in patients receiving long-term hemodialysis. Arch Intern Med. 1982;142:1448-52. [PMID: 6285845]
49. Liddle GW. Tests of pituitary adrenal suppressibility in the diagnosis of Cushing's syndrome. J Clin Endocrinol. 1960;12:1539-60.
50. Yanovski JA, Cutler GB Jr, Chrousos GP, Nieman LK. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states. JAMA. 1993;269:2232-8. [PMID: 8386285]
51. Wood PJ, Barth JH, Freedman DB, Perry L, Sheridan B. Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome-recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem. 1997;34(Pt 3):222-9. [PMID: 9158818]
52. Stratakis CA, Kirschner LS, Carney JA. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab. 2001;86:4041-6. [PMID: 11549623]
53. Lacroix A, Ndiaye N, Tremblay J, Hamet P. Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocr Rev. 2001;22:75-110. [PMID: 11159817]
54. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med. 1991;325:1688-95. [PMID: 1944469]
55. Klose M, Kofoed-Enevoldsen A, Ostergaard Kristensen L. Single determination of plasma ACTH using an immunoradiometric assay with high detect-ability differentiates between ACTH-dependent and -independent Cushing's syndrome. Scand J Clin Lab Invest. 2002;62:33-7. [PMID: 12002411]
56. Raff H, Findling JW. A new immunoradiometric assay for corticotropin evaluated in normal subjects and patients with Cushing's syndrome. Clin Chem. 1989;35:596-600. [PMID: 2539271]
57. Aron DC, Raff H, Findling JW. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab. 1997;82:1780-5. [PMID: 9177382]
58. Giraldi FP, Invitti C, Cavagnini F. The corticotropin-releasing hormone test in the diagnosis of ACTH-dependent Cushing's syndrome: a reappraisal. Clin Endocrinol (Oxf). 2001;54:601-7. [PMID: 11380490]
59. Becker M, Aron DC. Ectopic ACTH syndrome and CRH-mediated Cushing's syndrome. Endocrinol Metab Clin North Am. 1994;23:585-606. [PMID: 7805656]
60. Terzolo M, Reimondo G, Ali A, Borretta G, Cesario F, Pia A, et al. The limited value of the desmopressin test in the diagnostic approach to Cushing's syndrome. Clin Endocrinol (Oxf). 2001;54:609-16. [PMID: 11380491]
61. Booth GL, Redelmeier DA, Grosman H, Kovacs K, Smyth HS, Ezzat S. Improved diagnostic accuracy of inferior petrosal sinus sampling over imaging for localizing pituitary pathology in patients with Cushing's disease. J Clin Endocrinol Metab. 1998;83:2291-5. [PMID: 9661597]
62. Doppman JL, Frank JA, Dwyer AJ, Oldfield EH, Miller DL, Nieman LK, et al. Gadolinium DTPA enhanced MR imaging of ACTH-secreting microadenomas of the pituitary gland. J Comput Assist Tomogr. 1988;12:728-35. [PMID: 3170830]
63. Dwyer AJ, Frank JA, Doppman JL, Oldfield EH, Hickey AM, Cutler GB, et al. Pituitary adenomas in patients with Cushing disease: initial experience with Gd-DTPA-enhanced MR imaging. Radiology. 1987;163:421-6. [PMID: 3562821]
64. Hall WA, Luciano MG, Doppman JL, Patronas NJ, Oldfield EH. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med. 1994;120:817-20. [PMID: 8154641]
65. Findling JW, Kehoe ME, Shaker JL, Raff H. Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing's syndrome: early recognition of the occult ectopic ACTH syndrome. J Clin Endocrinol Metab. 1991;73:408-13. [PMID: 1649842]
66. Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA, et al. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med. 1991;325:897-905. [PMID: 1652686]
67. Oliverio PJ, Monsein LH, Wand GS, Debrun GM. Bilateral simultaneous cavernous sinus sampling using corricotropin-releasing hormone in the evaluation of Cushing disease. AJNR Am J Neuroradiol. 1996;17:1669-74. [PMID: 8896620]
68. Oldfield EH, Doppman JL. Petrosal versus cavernous sinus sampling [Letter]. J Neurosurg. 1998;89:890-3. [PMID: 9817432]
69. Landolt AM, Schubiger O, Maurer R, Girard J. The value of inferior petrosal sinus sampling in diagnosis and treatment of Cushing's disease. Clin Endocrinol (Oxf). 1994;40:485-92. [PMID: 8187314]
70. Blevins LS Jr, Clark RV, Owens DS. Thromboembolic complications after inferior petrosal sinus sampling in patients with Cushing's syndrome. Endocr Pract. 1998;4:365-7.
71. Bonelli FS, Huston J 3rd, Meyer FB, Carpenter PC. Venous subarachnoid hemorrhage after inferior petrosal sinus sampling for adrenocorticotropic hormone. AJNR Am J Neuroradiol. 1999;20:306-7. [PMID: 10094360]
72. Miller DL, Doppman JL, Peterman SB, Nieman LK, Oldfield EH, Chang R. Neurologic complications of petrosal sinus sampling. Radiology. 1992;185:143-7. [PMID: 1523298]
73. Obuobie K, Davies JS, Ogunko A, Scanlon MF. Venous thrombo-embolism following inferior petrosal sinus sampling in Cushing's disease. J Endocrinol Invest. 2000;23:542-4. [PMID: 11021772]